197 related articles for article (PubMed ID: 11364822)
1. Presumptive TB prophylaxis rejected.
Torres G
GMHC Treat Issues; 1997 Oct; 11(10):5-6. PubMed ID: 11364822
[TBL] [Abstract][Full Text] [Related]
2. Anergy skin testing and tuberculosis [corrected] preventive therapy for HIV-infected persons: revised recommendations. Centers for Disease Control and Prevention.
MMWR Recomm Rep; 1997 Sep; 46(RR-15):1-10. PubMed ID: 9332982
[TBL] [Abstract][Full Text] [Related]
3. Preventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre.
Aisu T; Raviglione MC; van Praag E; Eriki P; Narain JP; Barugahare L; Tembo G; McFarland D; Engwau FA
AIDS; 1995 Mar; 9(3):267-73. PubMed ID: 7755915
[TBL] [Abstract][Full Text] [Related]
4. Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease.
Graham NM; Galai N; Nelson KE; Astemborski J; Bonds M; Rizzo RT; Sheeley L; Vlahov D
Arch Intern Med; 1996 Apr; 156(8):889-94. PubMed ID: 8774208
[TBL] [Abstract][Full Text] [Related]
5. Tuberculosis vaccination versus isoniazid preventive therapy: a decision analysis to determine the preferred strategy of tuberculosis prevention in HIV-infected adults in the developing world.
Sterling TR; Brehm WT; Moore RD; Chaisson RE
Int J Tuberc Lung Dis; 1999 Mar; 3(3):248-54. PubMed ID: 10094327
[TBL] [Abstract][Full Text] [Related]
6. Instability of tuberculin and Candida skin test reactivity in HIV-infected Ugandans. The Uganda-Case Western Reserve University Research Collaboration.
Johnson JL; Nyole S; Okwera A; Whalen CC; Nsubuga P; Pekovic V; Huebner R; Wallis RS; Mugyenyi PN; Mugerwa RD; Ellner JJ
Am J Respir Crit Care Med; 1998 Dec; 158(6):1790-6. PubMed ID: 9847269
[TBL] [Abstract][Full Text] [Related]
7. Missed opportunities for prevention of tuberculosis among persons with HIV infection--selected locations, United States, 1996-1997.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2000 Aug; 49(30):685-7. PubMed ID: 10947056
[TBL] [Abstract][Full Text] [Related]
8. Influence of the human immunodeficiency virus in the incidence of tuberculosis in a cohort of intravenous drug users: effectiveness of anti-tuberculosis chemoprophylaxis.
Jansà JM; Serrano J; Caylà JA; Vidal R; Ocaña I; Español T
Int J Tuberc Lung Dis; 1998 Feb; 2(2):140-6. PubMed ID: 9580481
[TBL] [Abstract][Full Text] [Related]
9. Some HIV clinics changing protocols on anergy.
AIDS Alert; 1995 Apr; 10(4):suppl 1-2. PubMed ID: 11362253
[TBL] [Abstract][Full Text] [Related]
10. A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS.
Gordin FM; Matts JP; Miller C; Brown LS; Hafner R; John SL; Klein M; Vaughn A; Besch CL; Perez G; Szabo S; El-Sadr W
N Engl J Med; 1997 Jul; 337(5):315-20. PubMed ID: 9233868
[TBL] [Abstract][Full Text] [Related]
11. Isoniazid preventive therapy in human immunodeficiency virus-infected persons. Long-term effect on development of tuberculosis and survival.
Moreno S; Miralles P; Diaz MD; Baraia J; Padilla B; Berenguer J; Alberdi JC
Arch Intern Med; 1997 Aug 11-25; 157(15):1729-34. PubMed ID: 9250234
[TBL] [Abstract][Full Text] [Related]
12. CDC changing position on anergy testing, therapy. Centers for Disease Control and Prevention.
AIDS Alert; 1997 Oct; 12(10):117-8. PubMed ID: 11364718
[TBL] [Abstract][Full Text] [Related]
13. Mini epidemic of isoniazide resistant TB in rural TN: a need for supervised preventive therapy.
Mehta J; Keith R; Al Hasan M; Ryland B; Roy T
Tenn Med; 2009 Aug; 102(8):41-4. PubMed ID: 19691201
[TBL] [Abstract][Full Text] [Related]
14. Reduction of clinical tuberculosis in HIV-infected males with isoniazid prophylaxis.
Alaei K; Alaei A; Mansouri D
East Mediterr Health J; 2002 Nov; 8(6):754-7. PubMed ID: 15568452
[TBL] [Abstract][Full Text] [Related]
15. Preventing tuberculosis among HIV-infected persons: a survey of physicians' knowledge and practices.
DeRiemer K; Daley CL; Reingold AL
Prev Med; 1999 Apr; 28(4):437-44. PubMed ID: 10090874
[TBL] [Abstract][Full Text] [Related]
16. [The role of chemoprophylaxis in prevention of tuberculosis].
Jovanović D
Med Pregl; 2004; 57 Suppl 1():49-52. PubMed ID: 15686222
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of isoniazid treatment for latent tuberculosis infection among human immunodeficiency virus (HIV)-infected and HIV-uninfected injection drug users in methadone programs.
Scholten JN; Driver CR; Munsiff SS; Kaye K; Rubino MA; Gourevitch MN; Trim C; Amofa J; Seewald R; Highley E; Fujiwara PI
Clin Infect Dis; 2003 Dec; 37(12):1686-92. PubMed ID: 14689352
[TBL] [Abstract][Full Text] [Related]
18. Tuberculin skin test and chemoprophylaxis of tuberculosis.
Ortona L; Fantoni M
Rays; 1998; 23(1):218-24. PubMed ID: 9673147
[TBL] [Abstract][Full Text] [Related]
19. [Determination of antibodies against A-60 antigen for diagnosis of M. tuberculosis infection. A useful tool for rationalization of chemoprophylaxis in HIV patients].
Blanco JR; Martínez de Artola V; Ibarra V; Rosel L; Gómez-Cadiñanos R; Oteo JA
An Med Interna; 2001 Mar; 18(3):127-31. PubMed ID: 11594176
[TBL] [Abstract][Full Text] [Related]
20. Isoniazid TB prophylaxis effective in drug users with HIV.
J Int Assoc Physicians AIDS Care; 1996 Jun; 2(6):51. PubMed ID: 11363698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
